The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PEMBROCABOSARC: Combination of pembrolizumab and cabozantinib in patients with advanced sarcomas.
 
Sabrina Sellan-Albert
No Relationships to Disclose
 
Maud Toulmonde
Speakers' Bureau - Blueprint Medicines
Travel, Accommodations, Expenses - PharmaMar
 
Mariella Spalato
No Relationships to Disclose
 
Francois Bertucci
No Relationships to Disclose
 
Emmanuelle Bompas
No Relationships to Disclose
 
Isabelle Desmoulins
No Relationships to Disclose
 
Florence Duffaud
Consulting or Advisory Role - Bayer Health; Bayer Health; Bayer Health; BluPrint Oncology; Deciphera; GlaxoSmithKline
Travel, Accommodations, Expenses - Leo Pharma; PharmaMar; PharmaMar
 
Sophie Cousin
No Relationships to Disclose
 
Celine Auzanneau
No Relationships to Disclose
 
Barbara Lortal
No Relationships to Disclose
 
Marina Pulido
No Relationships to Disclose
 
François Le Loarer
No Relationships to Disclose
 
Antoine Italiano
Honoraria - Bayer; Daiichi Sankyo; Epizyme; IPSEN; Lilly; Novartis; Roche
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Epizyme; Immune Design; Lilly; Roche
Research Funding - AstraZeneca/MedImmune; Bayer; Merck Serono; Merck Serono; MSD Oncology; PharmaMar; Roche
Patents, Royalties, Other Intellectual Property - BMS